Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by OpGen, Inc.

OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Closing of $3.5 Million Public Offering
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Pricing of $3.5 Million Public Offering
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen’s Subsidiary Curetis Signs Expansion of R&D Collaboration with FIND
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen’s Subsidiary Curetis Meets Milestones in Collaborative Research Project with InfectoGnostics
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Subsidiary Ares Genetics Announces its Move to New Vienna Location and Provides Update on Business Growth
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Exercise of All Prefunded Warrants
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen subsidiary Ares Genetics announces granting of key patent in China
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Subsidiary Curetis Meets Several Key Milestones in FIND Collaboration Project
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Closing of $7.5 Million Public Offering
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Pricing of $7.5 Million Public Offering
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announced 1-for-20 Reverse Stock Split
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection Panel
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Reports Third Quarter 2022 Financial Results and Provides Business Update
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2022 and Provides Business Update
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen to Provide Business Update and Financial Results for the Third Quarter 2022 on November 10th at 4:30 p.m. Eastern Standard Time
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Subsidiary Curetis and BioVersys Sign Collaboration Agreement for Clinical Trial Support
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Closing of $3.38 Million Registered Direct Offering
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces Successful Completion of Clinical Trial Enrollment for Unyvero Urinary Tract Infection Panel
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Announces $3.38 Million Registered Direct Offering
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
From OpGen, Inc.
Via GlobeNewswire
Tickers OPGN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.